The signatures of the breast stem cells in the fetus were stunningly similar to the stem - like cells found
in aggressive breast cancers, including a significant fraction of a virulent cancer subtype known as «triple - negative.»
Not exact matches
The other, a former White House aide to President Obama, tested positive for the BRCA2 gene mutation that has led to
breast cancer in her family for generations — and is taking
aggressive steps to avoid the same fate.
My dear friend who died
in less than 18 months from
aggressive breast cancer was told by the vicar to apologise to the church committee about a minor matter or «consider her future as a member» (I helped her prepare her reply and told her that she couldn't say what she wanted to say, she was insistent but I was emphatic «it's not the content....
The woman asking this of her sister had been
in an out of the hospital struggling with an
aggressive breast cancer for three years.
He's proposing that New York state become home to the most
aggressive breast cancer screening program
in the country.
Toward that end, Cuomo's new budget proposal seeks $ 90 million to implement «the most
aggressive, best
breast cancer screening
in this country.»
«We are undertaking the most
aggressive action
in the nation to expand access to
breast cancer screenings, because early detection is the best possible treatment,» Cuomo said.
Under Governor Cuomo's leadership, the State has taken the most
aggressive action
in the nation to improve access to
breast cancer screening.
Cuomo proposed New York spend $ 91 million to make New York the state with the most
aggressive breast cancer screening program
in the country.
I propose $ 90 million to make New York where we have the most
aggressive breast cancer screening operation
in this country.
Medical opinion also varies on how the kind of
breast cancer Lee had, a noninvasive form called ductal carcinoma
in situ, should be treated, but Lee is adamant about early mammograms and
aggressive treatment.
She carried
in her cells a dangerous genetic mutation and died when she was 28, after refusing surgery for her
aggressive, inherited
breast cancer.
«Our discovery of these mutations is a first step
in developing a genetics - based system for classifying endometriosis so that clinicians can sort out which forms of the disorder may need more
aggressive treatment and which may not,» says Ie - Ming Shih, M.D., Ph.D., the Richard W. TeLinde Distinguished Professor
in the Department of Gynecology & Obstetrics at the Johns Hopkins University School of Medicine and co-director of the
Breast and Ovarian
Cancer Program at the Johns Hopkins Kimmel
Cancer Center.
«Study
in early stage
breast cancer shows that even small tumors can be
aggressive.»
«This study forms the basis for future research
in patients with
breast cancer and offers hope for targeted therapy for patients with
aggressive triple - negative inflammatory
breast cancer,» said lead researcher Mateusz Opyrchal, M.D., Ph.D., Assistant Professor of Oncology at RPCI.
«We discovered that the
aggressive cancer cells that are spreading
in colon,
breast, and skin
cancer contained a much higher portion of the protein PITPNC1, than the non-
aggressive cancer cells,» says researcher Nils Halberg of the CELLNET Group at the Department of Biomedicine at UiB.
PARP inhibitors have shown efficacy for a small group of patients with
breast cancer with inherited mutations
in BRCA genes, but have failed
in the more
aggressive triple - negative disease.
A COMPOUND that slows the proliferation of triple - negative
breast cancer cells
in lab tests could lead to the first drugs to target this
aggressive type of tumour.
Researchers
in China have discovered that a metabolic enzyme called AKR1B1 drives an
aggressive type of
breast cancer.
Recent studies have shown an increase
in women with
breast cancer choosing this more
aggressive surgery, called contralateral prophylactic mastectomy, which raises the question of potential overtreatment among these patients.
«By understanding how stress accelerates invasion
in aggressive breast tumor cells, this work will inform future studies into whether beta - blockers could be a useful adjuvant therapy
in the treatment of some
aggressive breast cancers.»
The study, which will be published December 21
in the Journal of Cell Biology, suggests that the loss of these particular Numb proteins makes
breast cancers more
aggressive and resistant to chemotherapy, but points the way toward new therapeutic approaches that could improve patient outcome by preserving p53 levels.
In the study, the genetic targets were messenger RNA (mRNA) that code for certain proteins known to be biomarkers for
aggressive breast cancer cells.
The old idea that
cancer is less
aggressive in the elderly is not entirely without merit:
breast and prostate
cancers tend to grow more slowly
in older patients.
A team of researchers led by UC San Francisco scientists has identified a new drug target for triple - negative
breast cancer, an
aggressive disease subtype that has the poorest outcomes and accounts for as many as one
in five cases.
«We found that PIM1 is indeed highly upregulated
in these more
aggressive breast cancers that have high MYC expression,» Goga said, «and that patients with high PIM1 tend to do more poorly.»
Researchers at Washington University School of Medicine
in St. Louis have discovered why
breast cancer patients with dense
breasts are more likely than others to develop
aggressive tumors that spread.
Previous
in vitro studies conducted by researchers
in other countries showed that this molecule was able to reduce the multiplication and increase the mortality of cells from melanoma, the most
aggressive type of skin
cancer, as well as
breast cancer and neuroblastoma, a tumor that typically affects patients aged 15 or younger.
The panel also called for «
aggressive research» on using RU486 and other drugs
in the antiprogrestin class as contraceptives and as treat - ment for endometriosis, uter - ine fibroids, advanced
breast cancer and meningioma brain tumours.
It has been recognized that the more
aggressive triple - negative
breast cancer occurs more frequently
in African American women, but no previous study has examined racial differences
in tumor genotype and how they might contribute to the risk of
cancer recurrence.
«
In addition to having a higher prevalence of triple - negative breast cancers than Caucasian women — something that has been documented in previous studies — we found that African American women with breast cancer had a significantly higher prevalence of the TP53 driver mutation, basal tumor subtype and greater genomic diversity within tumors, all of which suggest more aggressive tumor biology,» says Tanya Keenan, MD, of the MGH Cancer Center, lead author of the stud
In addition to having a higher prevalence of triple - negative
breast cancers than Caucasian women — something that has been documented
in previous studies — we found that African American women with breast cancer had a significantly higher prevalence of the TP53 driver mutation, basal tumor subtype and greater genomic diversity within tumors, all of which suggest more aggressive tumor biology,» says Tanya Keenan, MD, of the MGH Cancer Center, lead author of the stud
in previous studies — we found that African American women with
breast cancer had a significantly higher prevalence of the TP53 driver mutation, basal tumor subtype and greater genomic diversity within tumors, all of which suggest more aggressive tumor biology,» says Tanya Keenan, MD, of the MGH Cancer Center, lead author of the
cancer had a significantly higher prevalence of the TP53 driver mutation, basal tumor subtype and greater genomic diversity within tumors, all of which suggest more
aggressive tumor biology,» says Tanya Keenan, MD, of the MGH
Cancer Center, lead author of the
Cancer Center, lead author of the study.
Although
breast cancer is somewhat more
aggressive in South Asian and Black women than
in White women, this is largely due to age differences between ethnic groups
in the UK, according to new research.
The results suggest that the pockets of stiffer extracellular matrix
in the
breasts of obese women contribute to tumor growth as well as to more
aggressive cancers, Fischbach says: «People always think it's all about soluble factors, chemicals.
A new study shows coibamide A has potent anti-
cancer activity
in mice and cell cultures that model brain tumors and triple negative
breast cancer, two of the most
aggressive and difficult - to - treat types of
cancer.
Now, University of Pennsylvania researchers have revealed how a reduction
in mitochondrial DNA content leads human
breast cancer cells to take on
aggressive, metastatic properties.
The team's findings, published online
in Nature Cell Biology, explored HIF - 1's role
in triple - negative
breast cancer (TNBC), an
aggressive and hard - to - treat form of the disease.
The growth rate of the cells exploded, and they quickly became disorganized masses characteristic of early stage,
aggressive breast cancer, the team reports
in the 7 February issue of the Journal of Experimental Medicine.
Further, the relationship between Myc and TXNIP is not observed
in other types of
breast cancer, suggesting that it is a feature of only
aggressive triple negative
breast cancers and not other less
aggressive breast cancer types.
In the era of personalized
cancer therapy, patients with TNBC remain at considerably higher risk of relapse and death than patients with other
breast cancer subtypes, due to the
aggressive nature of TNBC and the lack of newer targeted therapies for the disease.
Researchers led by Dr. Debra Auguste, associate professor, biomedical engineering,
in the Grove School of Engineering at The City College of New York, have identified a molecule that could lead to developing treatment for one of the most
aggressive forms of
breast cancer.
Nuclear localization of KLF4 is associated with an
aggressive phenotype
in early - stage
breast cancer
Like pervasive hypertension, some
cancers, such as prostate and
breast, tend to occur earlier and be more
aggressive in blacks than whites, said Dr. Edward J. Kruse, chief of surgical oncology at MCG and the Georgia
Cancer Center.
Mutations
in the gene increase rat susceptibility to mammary
cancer and FRY reduced the growth of highly
aggressive human
breast cancer cells.
«What we see over and over
in trying to treat some of the most
aggressive and intractable
cancers, including many lung, brain, ovarian,
breast, melanoma and sarcoma tumors, is that the tumor fights back.
«Inflammatory
breast cancer is a rare and very
aggressive disease
in which
cancer cells block lymph vessels
in the skin of the
breast.
If validated
in larger studies, this breakthrough could mean that it may be possible to identify those at the highest risk of their
breast cancer spreading, with more
aggressive treatments targeted specifically to them, while those at low risk could be spared treatments that may not benefit them, as well as the subsequent side - effects.
The
aggressive basal - type
breast cancers often metastasize, seeding new tumors
in distant parts of the body.
A new score that could identify certain women with primary
breast cancer in need of more or less
aggressive treatments could play a pivotal role
in ensuring they are given the best possible chance of survival, while only giving treatments such as chemotherapy when it's necessary.
Scientists exploit gene therapy to shrink tumors
in mice with an
aggressive form of
breast cancer.
They are looking for protein indicators of
aggressive breast cancer in the tissue and plasma samples.